Malnutrition Clinical Trials

Find Malnutrition Clinical Trials Near You

Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice. STARLIGHT Study

Status: Recruiting
Location: See all (12) locations...
Study Type: Observational
SUMMARY

The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber. Participants will complete a series of questionnaires during visits 1 and 3.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients diagnosed with type 2 diabetes (T2D) or drug-induced diabetes

• Patients at nutritional risk according to MUST or presenting malnutrition according to GLIM criteria.

• Patients requiring a diabetes-specific oral nutritional supplement (ONS) that is high-calorie, high-protein, and contains soluble fiber in real-world clinical practice, and who have been prescribed such a supplement within the previous 7 days.

• Patients able to provide informed consent and complete the study questionnaires.

Locations
Other Locations
Spain
Hospital Universitario Juan Ramón Jiménez
RECRUITING
Huelva
Hospital UniversitarioDoctor Negrín
RECRUITING
Las Palmas De Gran Canaria
Hospital Clínico San Carlos
RECRUITING
Madrid
Hospital La Princesa
RECRUITING
Madrid
Hospital Universitario La Paz
RECRUITING
Madrid
Hospital Virgen de la Victoria
RECRUITING
Málaga
Hospital Universitario Central de Asturias
RECRUITING
Oviedo
Hospital Universitario Marqués de Valdecilla
RECRUITING
Santander
Hospital Universitario Virgen de la Macarena
RECRUITING
Seville
Hospital Universitario Virgen del Rocío
RECRUITING
Seville
Hospital General de Valencia
RECRUITING
Valencia
Hospital La Fe
RECRUITING
Valencia
Contact Information
Primary
Mercedes Blanco Naveira, Medical Adviser. MD
mercedes.blanco@es.nestle.com
+34 628 237 634
Time Frame
Start Date: 2025-11-20
Estimated Completion Date: 2026-10
Participants
Target number of participants: 334
Treatments
Patients with T2D or with drug-induced diabetes and malnutrition or at risk of it
Related Therapeutic Areas
Sponsors
Collaborators: Nestlé Health Science Spain
Leads: Outcomes'10

This content was sourced from clinicaltrials.gov